Interactive Robot-Guided Exercise Program for Cancer-Related Fatigue
Using an Interactive Kebbi Robot to Develop an Exercise Program for Cancer-Related Fatigue: Assessing Its Effectiveness
The goal of this study is to learn whether an exercise program guided by an interactive robot can help reduce tiredness in people with cancer. This kind of tiredness, called cancer-related fatigue, is common during cancer treatment and can make everyday activities harder.
People who take part in the exercise program will do sessions guided by the robot. Before and after each session, the study team checks things like heart rate, breathing rate, and blood pressure, and asks about tiredness and other symptoms.
Family members and nurses who help patients use the robot are also asked to share their views on how well the robot's teaching materials hold their attention and help them feel confident and satisfied.
Everyone who joins the exercise part of the study receives the same robot-guided program. There is no separate group that skips the robot program.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
Cancer-related fatigue is one of the most common and distressing symptoms experienced by patients undergoing cancer treatment, often persisting despite rest and negatively affecting daily function and quality of life. Exercise is a recommended non-pharmacological strategy to help manage this symptom, but adherence to conventional exercise programs among cancer patients is often limited.
This study develops and evaluates an exercise teaching program delivered through an interactive robot (Kebbi) for cancer patients treated at Taipei Medical University-affiliated Wanfang Hospital. The robot guides participants through a structured exercise routine. Physiological parameters (heart rate, respiratory rate, systolic and diastolic blood pressure) are recorded immediately before and after exercise sessions, and patient-reported fatigue and symptom burden are assessed repeatedly over the course of the intervention period.
In addition to the patient cohort, family caregivers and nursing staff who interact with the robot-based teaching materials are invited to evaluate the instructional design of the materials, focusing on their ability to engage attention, demonstrate relevance, build confidence, and achieve satisfaction.
This is a single-group study; all enrolled patients receive the robot-guided exercise program, and outcomes are compared within participants before versus after the intervention. No randomization or control group is used.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Taipei, Taiwan
- Wanfang Hospital
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Age 20 years or older
- Confirmed diagnosis of cancer, currently receiving anticancer treatment at Taipei Municipal Wanfang Hospital
- Presence of cancer-related fatigue (self-reported or clinically assessed)
- Sufficient cognitive and physical function to participate in a robot-guided, low-to-moderate intensity exercise program
- Willing and able to provide informed consent
Exclusion Criteria:
- Severe cognitive impairment or communication barriers preventing comprehension of study instructions
- Unstable cardiopulmonary or hemodynamic status contraindicating exercise
- Bedridden or physical performance status precluding participation in basic exercise movements
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Ei käytössä
- Inventiomalli: Yksittäinen ryhmätehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Robot-Guided Exercise Group
Cancer patients receiving the interactive robot (Kebbi)-guided exercise program.
Vital signs, fatigue, and symptom burden are assessed before and after sessions.
|
A structured exercise program delivered and guided by an interactive robot (Kebbi), designed to help manage cancer-related fatigue.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Cancer-Related Fatigue Severity
Aikaikkuna: Baseline (prior to intervention) through completion of the intervention (up to 5 days), assessed up to three times daily during the intervention period
|
Fatigue severity assessed using the Brief Fatigue Inventory (BFI), a self-reported measure with items rated from 0 (no fatigue) to 10 (fatigue as bad as you can imagine).
Higher scores indicate greater fatigue severity.
|
Baseline (prior to intervention) through completion of the intervention (up to 5 days), assessed up to three times daily during the intervention period
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Symptom Burden
Aikaikkuna: Baseline (prior to intervention) and immediately after completion of the intervention (up to 5 days)
|
Symptom burden assessed using the Edmonton Symptom Assessment Scale (ESAS), which rates the severity of multiple symptoms (e.g., pain, tiredness, drowsiness, nausea, appetite) on a 0-10 scale.
Higher scores indicate greater symptom severity.
|
Baseline (prior to intervention) and immediately after completion of the intervention (up to 5 days)
|
|
Change in Heart Rate
Aikaikkuna: Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
Heart rate (beats per minute) measured immediately before and immediately after each exercise session.
|
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
|
Change in Respiratory Rate
Aikaikkuna: Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
Respiratory rate (breaths per minute) measured immediately before and immediately after each exercise session.
|
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
|
Change in Systolic Blood Pressure
Aikaikkuna: Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
Systolic blood pressure (mmHg) measured immediately before and immediately after each exercise session.
|
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
|
Change in Diastolic Blood Pressure
Aikaikkuna: Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
Diastolic blood pressure (mmHg) measured immediately before and immediately after each exercise session.
|
Immediately before and immediately after each exercise session, up to 4 sessions within the 5-day intervention period
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muut tutkimustunnusnumerot
- ROBOT_education_N202407020
- TMU-JIRB (Muu tunniste: TMU-JIRB)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .